Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic multivirus-directed cytotoxic T lymphocytes (CTL)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic multivirus-directed cytotoxic T lymphocytes (CTL), covering 2025-07-03 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) [Phase 1]

See pricing